-
1
-
-
84902576469
-
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
Stone NJ, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2889-934.
-
(2014)
J Am Coll Cardiol.
, vol.63
, pp. 2889-2934
-
-
Stone, N.J.1
-
2
-
-
0024230807
-
High density lipoprotein cholesterol and mortality, The Framingham Heart Study
-
Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality, The Framingham Heart Study. Arteriosclerosis. 1988;8:737-41.
-
(1988)
Arteriosclerosis.
, vol.8
, pp. 737-741
-
-
Wilson, P.W.1
Abbott, R.D.2
Castelli, W.P.3
-
3
-
-
84855171302
-
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy
-
Boden WE, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255-67.
-
(2011)
N Engl J Med.
, vol.365
, pp. 2255-2267
-
-
Boden, W.E.1
-
4
-
-
34547652674
-
National estimates of severe sepsis in United States emergency departments
-
Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007;35:1928-36.
-
(2007)
Crit Care Med.
, vol.35
, pp. 1928-1936
-
-
Wang, H.E.1
Shapiro, N.I.2
Angus, D.C.3
Yealy, D.M.4
-
5
-
-
0034924156
-
Epidemiology of sepsis: an update
-
Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29:S109-16.
-
(2001)
Crit Care Med.
, vol.29
, pp. 109-116
-
-
Angus, D.C.1
Wax, R.S.2
-
6
-
-
0034958947
-
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
-
Angus DC, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.
-
(2001)
Crit Care Med.
, vol.29
, pp. 1303-1310
-
-
Angus, D.C.1
-
8
-
-
3042606551
-
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host
-
Khovidhunkit W, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45:1169-96.
-
(2004)
J Lipid Res.
, vol.45
, pp. 1169-1196
-
-
Khovidhunkit, W.1
-
9
-
-
55449105230
-
High-density lipoprotein reduces the human monocyte inflammatory response
-
Murphy AJ, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28:2071-7.
-
(2008)
Arterioscler Thromb Vasc Biol.
, vol.28
, pp. 2071-2077
-
-
Murphy, A.J.1
-
10
-
-
79957533056
-
Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation
-
Murphy AJ, et al. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol. 2011;31:1333-41.
-
(2011)
Arterioscler Thromb Vasc Biol.
, vol.31
, pp. 1333-1341
-
-
Murphy, A.J.1
-
11
-
-
0035960677
-
Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease
-
Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673-8.
-
(2001)
Circulation.
, vol.104
, pp. 2673-2678
-
-
Heitzer, T.1
Schlinzig, T.2
Krohn, K.3
Meinertz, T.4
Münzel, T.5
-
12
-
-
23844507487
-
Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis
-
Chien J-Y, Jerng J-S, Yu C-J, Yang P-C. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33:1688-93.
-
(2005)
Crit Care Med.
, vol.33
, pp. 1688-1693
-
-
Chien, J.-Y.1
Jerng, J.-S.2
Yu, C.-J.3
Yang, P.-C.4
-
13
-
-
84928583153
-
Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission
-
Chien Y-F, Chen C-Y, Hsu C-L, Chen K-Y, Yu C-J. Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission. J Crit Care. 2015;30:506-10.
-
(2015)
J Crit Care.
, vol.30
, pp. 506-510
-
-
Chien, Y.-F.1
Chen, C.-Y.2
Hsu, C.-L.3
Chen, K.-Y.4
Yu, C.-J.5
-
14
-
-
0038582331
-
Lipoprotein metabolism in patients with severe sepsis
-
van Leeuwen HJ, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med. 2003;31:1359-66.
-
(2003)
Crit Care Med.
, vol.31
, pp. 1359-1366
-
-
Leeuwen, H.J.1
-
15
-
-
0031296903
-
Lipoproteins: are they important components of host defense
-
Feingold KR, Grunfeld C. Lipoproteins: are they important components of host defense Hepatology. 1997;26:1685-6.
-
(1997)
Hepatology.
, vol.26
, pp. 1685-1686
-
-
Feingold, K.R.1
Grunfeld, C.2
-
16
-
-
84899586503
-
Low preoperative cholesterol level is a risk factor of sepsis and poor clinical outcome in patients undergoing cardiac surgery with cardiopulmonary bypass
-
Lagrost L, et al. Low preoperative cholesterol level is a risk factor of sepsis and poor clinical outcome in patients undergoing cardiac surgery with cardiopulmonary bypass. Crit Care Med. 2014;42:1065-73.
-
(2014)
Crit Care Med.
, vol.42
, pp. 1065-1073
-
-
Lagrost, L.1
-
17
-
-
84868282970
-
Chronic medical conditions and risk of sepsis
-
Wang HE, et al. Chronic medical conditions and risk of sepsis. PLoS One. 2012;7:e48307.
-
(2012)
PLoS One.
, vol.7
-
-
Wang, H.E.1
-
18
-
-
23944505195
-
The reasons for geographic and racial differences in stroke study: objectives and design
-
Howard VJ, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135-43.
-
(2005)
Neuroepidemiology.
, vol.25
, pp. 135-143
-
-
Howard, V.J.1
-
19
-
-
84873022321
-
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and In
-
Patel MR, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and In. J Thorac Cardiovasc Surg. 2012;143:780-803.
-
(2012)
J Thorac Cardiovasc Surg.
, vol.143
, pp. 780-803
-
-
Patel, M.R.1
-
20
-
-
0022632510
-
Concurrent and predictive validity of a self-reported measure of medication adherence
-
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
-
(1986)
Med Care.
, vol.24
, pp. 67-74
-
-
Morisky, D.E.1
Green, L.W.2
Levine, D.M.3
-
22
-
-
84908142666
-
Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis
-
Johansen KL, et al. Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. Am J Kidney Dis. 2014;64:600-7.
-
(2014)
Am J Kidney Dis.
, vol.64
, pp. 600-607
-
-
Johansen, K.L.1
-
23
-
-
25144445282
-
Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative observational study
-
Woods NF, et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative observational study. J Am Geriatr Soc. 2005;53:1321-30.
-
(2005)
J Am Geriatr Soc.
, vol.53
, pp. 1321-1330
-
-
Woods, N.F.1
-
24
-
-
0030015661
-
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine
-
Vincent JL, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.
-
(1996)
Intensive Care Med
, vol.22
, pp. 707-710
-
-
Vincent, J.L.1
-
25
-
-
84959273475
-
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
-
Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801.
-
(2016)
JAMA
, vol.315
, pp. 801
-
-
Singer, M.1
-
26
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
-
(1972)
Clin Chem.
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
27
-
-
0025801348
-
Multiple imputation in health-care databases: an overview and some applications
-
Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10:585-98.
-
(1991)
Stat Med.
, vol.10
, pp. 585-598
-
-
Rubin, D.B.1
Schenker, N.2
-
28
-
-
0030539070
-
Multiple imputation after 18+ years
-
Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996;91:473-89.
-
(1996)
J Am Stat Assoc.
, vol.91
, pp. 473-489
-
-
Rubin, D.B.1
-
29
-
-
69949108828
-
Imputing missing covariate values for the Cox model
-
White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28:1982-98.
-
(2009)
Stat Med.
, vol.28
, pp. 1982-1998
-
-
White, I.R.1
Royston, P.2
-
30
-
-
77949688477
-
Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients
-
Grion CM, et al. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients. Eur J Clin Invest. 2010;40:330-8.
-
(2010)
Eur J Clin Invest.
, vol.40
, pp. 330-338
-
-
Grion, C.M.1
-
31
-
-
84940870744
-
Prognostic implications of serum lipid metabolism over time during sepsis
-
Lee SH, et al. Prognostic implications of serum lipid metabolism over time during sepsis. Biomed Res Int. 2015;2015:789298.
-
(2015)
Biomed Res Int.
, vol.2015
, pp. 789298
-
-
Lee, S.H.1
-
32
-
-
0024361642
-
Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyltransferase and lipase deficiency
-
Auerbach BJ, Parks JS. Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyltransferase and lipase deficiency. J Biol Chem. 1989;264:10264-70.
-
(1989)
J Biol Chem.
, vol.264
, pp. 10264-10270
-
-
Auerbach, B.J.1
Parks, J.S.2
-
33
-
-
0025328366
-
Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys
-
Ettinger WH, Miller LD, Albers JJ, Smith TK, Parks JS. Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys. J Lipid Res. 1990;31:1099-107.
-
(1990)
J Lipid Res.
, vol.31
, pp. 1099-1107
-
-
Ettinger, W.H.1
Miller, L.D.2
Albers, J.J.3
Smith, T.K.4
Parks, J.S.5
-
34
-
-
0023821032
-
Modifications of plasma lipids, lipoproteins and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells
-
Malmendier CL, Lontie JF, Sculier JP, Dubois DY. Modifications of plasma lipids, lipoproteins and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells. Atherosclerosis. 1988;73:173-80.
-
(1988)
Atherosclerosis.
, vol.73
, pp. 173-180
-
-
Malmendier, C.L.1
Lontie, J.F.2
Sculier, J.P.3
Dubois, D.Y.4
-
35
-
-
0025181986
-
Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein
-
Rosenzweig IB, et al. Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein. Biotherapy. 1990;2:193-8.
-
(1990)
Biotherapy.
, vol.2
, pp. 193-198
-
-
Rosenzweig, I.B.1
-
36
-
-
0023221176
-
Plasma lipoprotein changes in humans induced by beta-interferon
-
Rosenzweig IB, Wiebe DA, Borden EC, Storer B, Shrago ES. Plasma lipoprotein changes in humans induced by beta-interferon. Atherosclerosis. 1987;67:261-7.
-
(1987)
Atherosclerosis.
, vol.67
, pp. 261-267
-
-
Rosenzweig, I.B.1
Wiebe, D.A.2
Borden, E.C.3
Storer, B.4
Shrago, E.S.5
-
37
-
-
0023778218
-
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study
-
Spriggs DR, et al. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst. 1988;80:1039-44.
-
(1988)
J Natl Cancer Inst
, vol.80
, pp. 1039-1044
-
-
Spriggs, D.R.1
-
38
-
-
0038104808
-
Distribution and kinetics of lipoprotein-bound lipoteichoic acid
-
Levels JHM, Abraham PR, van Barreveld EP, Meijers JCM, van Deventer SJH. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun. 2003;71:3280-4.
-
(2003)
Infect Immun.
, vol.71
, pp. 3280-3284
-
-
Levels, J.H.M.1
Abraham, P.R.2
Barreveld, E.P.3
Meijers, J.C.M.4
Deventer, S.J.H.5
-
39
-
-
84864845456
-
Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study
-
Voight BF, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet (London, England). 2012;380:572-80.
-
(2012)
Lancet (London, England)
, vol.380
, pp. 572-580
-
-
Voight, B.F.1
-
40
-
-
48749102531
-
Can dysfunctional HDL explain high coronary artery disease risk in South Asians
-
Dodani S, et al. Can dysfunctional HDL explain high coronary artery disease risk in South Asians Int J Cardiol. 2008;129:125-32.
-
(2008)
Int J Cardiol.
, vol.129
, pp. 125-132
-
-
Dodani, S.1
-
41
-
-
0028859490
-
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures
-
Van Lenten BJ, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995;96:2758-67.
-
(1995)
J Clin Invest.
, vol.96
, pp. 2758-2767
-
-
Lenten, B.J.1
-
42
-
-
84908407686
-
Carotid intima media thickness and low high-density lipoprotein (HDL) in South Asian immigrants: could dysfunctional HDL be the missing link
-
Dodani S, Dong L, Guirgis FW, Reddy ST. Carotid intima media thickness and low high-density lipoprotein (HDL) in South Asian immigrants: could dysfunctional HDL be the missing link Arch Med Sci. 2014;10:870-9.
-
(2014)
Arch Med Sci.
, vol.10
, pp. 870-879
-
-
Dodani, S.1
Dong, L.2
Guirgis, F.W.3
Reddy, S.T.4
-
43
-
-
66349127140
-
The role of dysfunctional HDL in atherosclerosis
-
Navab M, Reddy ST, Van Lenten BJ, Anantharamaiah GM, Fogelman AM. The role of dysfunctional HDL in atherosclerosis. J Lipid Res. 2009;50(Suppl):S145-9.
-
(2009)
J Lipid Res.
, vol.50
, pp. S145-S149
-
-
Navab, M.1
Reddy, S.T.2
Lenten, B.J.3
Anantharamaiah, G.M.4
Fogelman, A.M.5
-
44
-
-
0034891279
-
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
-
Navab M, et al. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res. 2001;42:1308-17.
-
(2001)
J Lipid Res.
, vol.42
, pp. 1308-1317
-
-
Navab, M.1
-
45
-
-
84908229451
-
PCSK9 is a critical regulator of the innate immune response and septic shock outcome
-
Walley KR, et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Sci Transl Med. 2014;6:258ra143.
-
(2014)
Sci Transl Med
, vol.6
-
-
Walley, K.R.1
-
46
-
-
84954410240
-
Increased plasma PCSK9 levels are associated with reduced endotoxin clearance and the development of acute organ failures during sepsis
-
Boyd JH, et al. Increased plasma PCSK9 levels are associated with reduced endotoxin clearance and the development of acute organ failures during sepsis. J Innate Immun. 2016;8:211-20.
-
(2016)
J Innate Immun.
, vol.8
, pp. 211-220
-
-
Boyd, J.H.1
-
49
-
-
84948410277
-
Resolvin infectious inflammation by targeting the host response
-
Lee CR, Zeldin DC. Resolvin infectious inflammation by targeting the host response. N Engl J Med. 2015;373:2183-5.
-
(2015)
N Engl J Med.
, vol.373
, pp. 2183-2185
-
-
Lee, C.R.1
Zeldin, D.C.2
-
50
-
-
84938061992
-
Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin
-
Ouellette DR, Moscoso EE, Corrales JP, Peters M. Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin. Ann Intensive Care. 2015;5:9.
-
(2015)
Ann Intensive Care.
, vol.5
, pp. 9
-
-
Ouellette, D.R.1
Moscoso, E.E.2
Corrales, J.P.3
Peters, M.4
-
51
-
-
85006935483
-
Chronic Statin Use and Long-Term Rates of Sepsis: A Population-Based Cohort Study
-
Wang HE, Griffin R, Shapiro NI, Howard G, Safford MM. Chronic Statin Use and Long-Term Rates of Sepsis: A Population-Based Cohort Study. J Intensive Care Med. 2016;31(6):386-96.
-
(2016)
J Intensive Care Med
, vol.31
, Issue.6
, pp. 386-396
-
-
Wang, H.E.1
Griffin, R.2
Shapiro, N.I.3
Howard, G.4
Safford, M.M.5
-
52
-
-
84934449856
-
Statin therapy in critically-ill patients with severe sepsis: a review and meta-analysis of randomized clinical trials
-
Thomas G, et al. Statin therapy in critically-ill patients with severe sepsis: a review and meta-analysis of randomized clinical trials. Minerva Anestesiol. 2015;81:921-30.
-
(2015)
Minerva Anestesiol.
, vol.81
, pp. 921-930
-
-
Thomas, G.1
-
53
-
-
84929517848
-
Statin therapy and mortality from sepsis: a meta-analysis of randomized trials
-
Deshpande A, Pasupuleti V, Rothberg MB. Statin therapy and mortality from sepsis: a meta-analysis of randomized trials. Am J Med. 2015;128:410-7.e1.
-
(2015)
Am J Med
, vol.128
, pp. 410-417.e1
-
-
Deshpande, A.1
Pasupuleti, V.2
Rothberg, M.B.3
|